Logo
DCA

Madrigal Pharmaceuticals, Inc.

MDGL•Healthcare•Biotechnology
488,15 $US
+7.79%
Letzter Preis
488,15 $US
2026-06-03
24h Änderung
+7.79%
35.29 USD
Volumen
261.264
Gehandelte Anteile
Datenzuverlässigkeit
Hoch
4862 Punkte (19 Jahre)

Kursentwicklung

Starten Sie eine Simulation mit diesem Asset

MDGL

Globale Parameter

Verfügbare Daten von 6.2.2007 bis 3.6.2026

Fundamentalanalyse

New
CAGR (5y)
432.66%
Revenue Growth
Net Margin
-30.08%
Profitability
ROE
-47.83%
Return on Equity
Debt / EBITDA
0.00
Solvency
PEG Ratio
-
Valuation vs Growth
Rev. Growth (TTM)
126.80%
Current Trend
Technischer Fokus
MDGL
30d-Volatilität
90.23%
Abstand zur MA50
-5.18%
Abstand zur MA200
-0.25%
Abstand zum ATH
-19.02%
Momentum 3M
11.11%
Risiko-Score
N/A

Moderate Volatilität. Momentum neutral.

Über Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Website besuchen ↗
In diesen Wert investieren
Kaufen bei Saxo Bank
🏦Regulierter Broker
🌍Globaler Marktzugang
📈Profi-Tools

Werbelink. Kapital unterliegt Risiken.

Technische Analyse & Risiko

Schlüsselkennzahlen

CAGR2.24%
Volatilität90.23%
Max Drawdown-56.45%

Momentum : MDGL

Indicateur synthétique
PEURNEUTREAVIDITÉ
42
Fear

Risikoanalyse

VaR (95%)-5.90%
DCA Gesundheit
48/100

Jüngste Geschichte (60 Tage)

DatumSchlusskursVolumen
2026-06-03488,15 $US261.264
2026-06-02452,86 $US425.217
2026-06-01481,23 $US234.002
2026-05-29497,27 $US322.287
2026-05-28515,96 $US235.808
2026-05-27527,67 $US144.100
2026-05-26524,28 $US260.000
2026-05-22517,26 $US156.952
2026-05-21513,59 $US201.606
2026-05-20513,47 $US312.903
2026-05-19511,82 $US255.784
2026-05-18522,23 $US322.877
2026-05-15523,69 $US222.453
2026-05-14539,89 $US334.998
2026-05-13518,87 $US366.756
2026-05-12510,26 $US217.857
2026-05-11497,03 $US305.905
2026-05-08510,04 $US377.506
2026-05-07534,86 $US383.168
2026-05-06539,73 $US512.464
2026-05-05502,47 $US331.045
2026-05-04518,66 $US180.170
2026-05-01513,72 $US186.480
2026-04-30517,39 $US224.318
2026-04-29518,58 $US151.065
2026-04-28516,69 $US213.334
2026-04-27520,09 $US209.961
2026-04-24512,39 $US200.289
2026-04-23518,74 $US330.184
2026-04-22529,14 $US197.797
2026-04-21527,69 $US199.770
2026-04-20527,11 $US251.277
2026-04-17532,02 $US341.067
2026-04-16524,76 $US195.925
2026-04-15518,58 $US223.723
2026-04-14524,99 $US296.403
2026-04-13525,67 $US320.453
2026-04-10519,61 $US292.045
2026-04-09524,30 $US263.883
2026-04-08519,75 $US340.344
2026-04-07511,89 $US343.347
2026-04-06533,88 $US293.919
2026-04-02546,89 $US344.955
2026-04-01529,84 $US411.329
2026-03-31523,47 $US505.848
2026-03-30505,34 $US318.176
2026-03-27510,68 $US487.145
2026-03-26518,76 $US1.344.773
2026-03-25461,93 $US294.274
2026-03-24445,04 $US197.756
2026-03-23447,72 $US218.104
2026-03-20441,16 $US467.748
2026-03-19454,22 $US272.632
2026-03-18442,00 $US309.524
2026-03-17443,18 $US162.672
2026-03-16440,83 $US343.274
2026-03-13444,83 $US218.541
2026-03-12438,73 $US285.924
2026-03-11431,53 $US279.392
2026-03-10432,78 $US254.500

Verwandte Assets

Eli Lilly and CompanyLLY.NEHealthcareEli Lilly and CompanyLLYHealthcareJohnson & JohnsonJNJHealthcareAbbVie Inc.ABBV.NEHealthcareJohnson & JohnsonJNJ0.FHealthcareAbbVie Inc.ABBVHealthcare